LONDON: The UK announced Friday that it would offer new vaccinations to thousands of people who voluntarily for the novavax coronavirus vaccine trial, which has not been approved for use in any country.
About 15,000 people in the UK got a novavaks shot as part of the clinical trial.
While England recognized him as vaccination, most countries did not, which meant they could not travel.
The British health department said more than 15,000 participants would be given two doses of the Pfizer / Bionontech vaccine.
The government said it planned to expand the offer to around 6,000 English participants in other vaccine trials which have not yet been approved for use.
The UK has appealed to other members of the group of 20 countries to classify volunteer clinical trials as vaccinations, but most have not done so.
British medical deputy officer Jonathan Van-Tam recorded that “ if more countries around the world have replied by allowing British volunteers to enjoy the status that was fully vaccinated for foreign trips, these steps were not necessary.
“In June, Novavax announced that the vaccine had been proven to be around 90% effective against Covid-19 symptomatic in a study of nearly 30,000 people in the US and Mexico.
US-based NovaVax has asked the World Health Organization to approve the Covid-19 vaccine for emergency use so that it can be part of the Global Covax vaccine program.
But it has delayed seeking approval in Europe or the United States.
Novavax shots are easier to be stored and transported than some other options, and have long been expected to play an important role in increasing supply in poor countries that are desperate for more vaccine doses.